Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Global SYMPLICITY Registry (GSR) DEFINE
This entry notes that the Global SYMPLICITY Registry DEFINE is currently recruiting participants for hypertension. The sponsor listed is Med…
-
FDA approval · 2025-11-25FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic irbesartan and hydrochlorothiazide fixed-dose combination tablet manufactured by M…
-
FDA approval · 2025-11-25FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for irbesartan filed by NorthStar RxLLC under ANDA 202254, authorizing changes to the product's appr…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function [NA]
This clinical trial is evaluating the dose-response effects of inspiratory muscle strength training on blood pressure and vascular function …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health [NA]
The DREAM Study is a recruiting clinical trial led by Columbia University evaluating a multidimensional sleep health intervention to improve…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Precision Nudging for Hypertension Management: Observational Study
An observational study titled 'Precision Nudging for Hypertension Management' sponsored by Lirio is currently recruiting.
-
FDA approval · 2025-11-24FDA Approved: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Micro Labs Limited)
The FDA approved a fixed-dose combination tablet containing olmesartan medoxomil, amlodipine besilate, and hydrochlorothiazide under Micro L…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Dietary Nitrate and the Oral Microbiome in Children With Primary Hypertension
This clinical trial update describes a study examining how dietary nitrate affects the oral microbiome in children with primary hypertension…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension [Phase 3]
A Phase 3 study to evaluate the efficacy and safety of TCA108 in adults with uncontrolled hypertension; the trial status is not yet recruiti…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor [NA]
The PACESETTER trial evaluated electronic tracking and tailored risk-factor management to prevent cerebrovascular events in people with hype…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial [NA]
A recruiting randomized trial examining how melatonin affects cardiovascular disease mechanisms in midlife women with perimenopause and hype…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity [Phase 4]
Phase 4 trial update evaluating sacubitril/alisartan for hypertension in overweight or obese patients; the study status is NOT_YET_RECRUITIN…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Antihypertensive Drug Selection Based on Hemodynamic Phenotypes [Phase 4]
Phase 4 clinical trial evaluating antihypertensive drug selection based on hemodynamic phenotypes; the study is currently not yet recruiting…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM) [NA]
This clinical trial evaluates the accuracy of a cuffless photoplethysmography chest-patch monitor for 24-hour ambulatory blood pressure moni…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Tension and Trauma Releasing Exercises on Hypertensive Patients [NA]
This clinical trial from Cairo University is investigating Tension and Trauma Releasing Exercises for people with hypertension, and it is cu…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Managing Hypertension Among People Living With HIV [NA]
ClinicalTrials.gov entry notes a completed study on managing hypertension among people living with HIV. No results are described in the prov…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Beach Tennis And Hypertension Study 2 [NA]
A completed clinical trial update for the Beach Tennis And Hypertension Study 2 sponsored by Hospital de Clinicas de Porto Alegre; the study…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Effectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in Taiwan [NA]
A completed clinical trial from Chang Gung Memorial Hospital evaluating the effectiveness of a digital health intervention on community heal…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes [NA]
A university-sponsored clinical trial is evaluating how a Mediterranean diet with potatoes affects heart and metabolic health in adults with…
-
CLINICAL_TRIALS other · 2025-11-20Clinical Trial Update: Efficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation [NA]
A clinical trial assessing the efficacy and safety of non-invasive temporal interference stimulation for blood pressure regulation is not ye…
-
EMA approval · 2025-11-19EMA Authorised: Dafiro (amlodipine;valsartan) — Novartis Europharm Limited
The EMA authorised Dafiro, a fixed-dose combination of amlodipine and valsartan, for the treatment of hypertension, with Novartis Europharm …
-
EMA approval · 2025-11-19EMA Authorised: Copalia (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Limited
The European Medicines Agency authorised Copalia, a fixed-dose combination of valsartan and amlodipine, for hypertension.
-
EMA approval · 2025-11-19EMA Authorised: Exforge (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Limited
The EMA authorised Exforge, a fixed-dose combination of valsartan and amlodipine, for hypertension; the marketing authorization holder is No…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: The Effects of Bifidobacterium-based Probiotics in Reducing Blood Pressure in Middle-aged Chinese With Hypertension [Phase 1]
A Phase 1 clinical trial at The University of Hong Kong is investigating whether bifidobacterium-based probiotics can reduce blood pressure …
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: ModPG3 Adult/Ped ISO 81060-2:2018 Study Protocol
The ModPG3 adult/pediatric BP measurement study protocol under ISO 81060-2:2018 was terminated, and results were posted on 2025-11-19.